Mealey's (March 13, 2023, 9:38 AM EDT) -- PHILADELPHIA — A federal judge in Pennsylvania issued a corrected order granting final approval of a $1.4 million settlement in a securities class action against a specialty pharmaceutical company and three of its senior executives on allegations that the defendants misrepresented the efficacy and manufacturing quality control for the development of the company’s non-opioid therapeutic drug candidate to reflect that certain taxes and expenses would be deducted from the net settlement fund balance that will be paid to the settlement class....